These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 9667563)
1. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. Schrag A; Kingsley D; Phatouros C; Mathias CJ; Lees AJ; Daniel SE; Quinn NP J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):65-71. PubMed ID: 9667563 [TBL] [Abstract][Full Text] [Related]
2. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease? Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of Parkinsonism-Predominant Multiple System Atrophy from Idiopathic Parkinson Disease Using 3T Susceptibility-Weighted MR Imaging, Focusing on Putaminal Change and Lesion Asymmetry. Hwang I; Sohn CH; Kang KM; Jeon BS; Kim HJ; Choi SH; Yun TJ; Kim JH AJNR Am J Neuroradiol; 2015 Dec; 36(12):2227-34. PubMed ID: 26338919 [TBL] [Abstract][Full Text] [Related]
4. Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study. Wang N; Yang H; Li C; Fan G; Luo X Eur Radiol; 2017 Aug; 27(8):3174-3180. PubMed ID: 28105503 [TBL] [Abstract][Full Text] [Related]
5. Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. Sugiyama A; Ito S; Suichi T; Sakurai T; Mukai H; Yokota H; Yonezu T; Kuwabara S J Neurol Sci; 2015 Feb; 349(1-2):174-8. PubMed ID: 25619571 [TBL] [Abstract][Full Text] [Related]
6. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy. Sakurai K; Kawaguchi T; Kawai T; Ogino H; Hara M; Okita K; Yamawaki T; Shibamoto Y Neuroradiology; 2010 Sep; 52(9):809-14. PubMed ID: 19894040 [TBL] [Abstract][Full Text] [Related]
8. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Watanabe H; Ito M; Fukatsu H; Senda J; Atsuta N; Kaga T; Kato S; Katsuno M; Tanaka F; Hirayama M; Naganawa S; Sobue G Mov Disord; 2010 Sep; 25(12):1916-23. PubMed ID: 20623769 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660 [TBL] [Abstract][Full Text] [Related]
10. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy. Lee JY; Yun JY; Shin CW; Kim HJ; Jeon BS J Neurol; 2010 Dec; 257(12):2065-70. PubMed ID: 20652301 [TBL] [Abstract][Full Text] [Related]
11. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis. Krismer F; Seppi K; Göbel G; Steiger R; Zucal I; Boesch S; Gizewski ER; Wenning GK; Poewe W; Scherfler C Mov Disord; 2019 Jul; 34(7):1041-1048. PubMed ID: 30919495 [TBL] [Abstract][Full Text] [Related]
12. T2*-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians. von Lewinski F; Werner C; Jörn T; Mohr A; Sixel-Döring F; Trenkwalder C J Neurol; 2007 Sep; 254(9):1184-8. PubMed ID: 17361340 [TBL] [Abstract][Full Text] [Related]
13. Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders. Calloni SF; Conte G; Sbaraini S; Cilia R; Contarino VE; Avignone S; Sacilotto G; Pezzoli G; Triulzi FM; Scola E Eur J Radiol; 2018 Dec; 109():95-100. PubMed ID: 30527319 [TBL] [Abstract][Full Text] [Related]
14. [Phase-weighted imaging in differentiating multiple system atrophy from idiopathic Parkinson disease]. Feng F; You H; Wang H; Zheng FL; Jin ZY; Cui LY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):129-33. PubMed ID: 19507587 [TBL] [Abstract][Full Text] [Related]
15. A study of parkinsonism in multiple system atrophy: clinical and MRI correlation. Wakai M; Kume A; Takahashi A; Ando T; Hashizume Y Acta Neurol Scand; 1994 Oct; 90(4):225-31. PubMed ID: 7839806 [TBL] [Abstract][Full Text] [Related]
16. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography]. Csoti I; Warmuth-Metz M; Solymosi L; Becker Dagger G; Fornadi F; Naumann M Nervenarzt; 2004 Feb; 75(2):128-34. PubMed ID: 14770282 [TBL] [Abstract][Full Text] [Related]
17. Hyperintense putaminal rim at 1.5 T: prevalence in normal subjects and distinguishing features from multiple system atrophy. Tha KK; Terae S; Tsukahara A; Soma H; Morita R; Yabe I; Ito YM; Sasaki H; Shirato H BMC Neurol; 2012 Jun; 12():39. PubMed ID: 22708511 [TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Schocke MF; Seppi K; Esterhammer R; Kremser C; Jaschke W; Poewe W; Wenning GK Neurology; 2002 Feb; 58(4):575-80. PubMed ID: 11865135 [TBL] [Abstract][Full Text] [Related]